Venlafaxine XR Does Not Alter Biomarkers of Bone Turnover in Older Adults With Major Depressive Disorder

被引：0
|
作者：
Shea, Marcie L. [1 ]
Garfield, Lauren D. [1 ]
Mulsant, Benoit H. [2 ]
Reynolds, Charles [3 ]
Civitelli, Roberto [1 ]
Teitelbaum, Steven [1 ]
Lenze, Eric J. [1 ]
机构：
[1] Washington Univ, St Louis, MO USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Pittsburgh, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 2012年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
EI 50
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [31] Similar effects of tramadol and venlafaxine in major depressive disorder
    Reeves, Roy R.
    Cox, Sera K.
    SOUTHERN MEDICAL JOURNAL, 2008, 101 (02) : 193 - 195
  • [32] Pharmacoeconomic analysis of venlafaxine in the treatment of major depressive disorder
    Einarson, TR
    Addis, A
    Iskedjian, M
    PHARMACOECONOMICS, 1997, 12 (02) : 286 - 296
  • [33] A randomized controlled trial of venlafaxine XR for major depressive disorder after spinal cord injury: Methods and lessons learned
    Bombardier, Charles H.
    Fann, Jesse R.
    Wilson, Catherine S.
    Heinemann, Allen W.
    Richards, J. Scott
    Warren, Ann Marie
    Brooks, Larry
    Warms, Catherine A.
    Temkin, Nancy R.
    Tate, Denise G.
    JOURNAL OF SPINAL CORD MEDICINE, 2014, 37 (03): : 247 - 263
  • [34] Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland
    Benedict, Agnes
    Arellano, Jorge
    De Cock, Erwin
    Baird, Jessamy
    JOURNAL OF AFFECTIVE DISORDERS, 2010, 120 (1-3) : 94 - 104
  • [35] COST-UTILITY ANALYSIS EVALUATING VORTIOXETINE VERSUS VENLAFAXINE XR AND AGOMELATINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN TAIWAN
    Brignone, M.
    Atsou, K.
    Reynaud-Mougin, C.
    Chen, W.
    Milea, D.
    VALUE IN HEALTH, 2016, 19 (07) : A841 - A842
  • [36] Major Depressive Disorder and Bone Mass in Adolescents and Young Adults
    Calarge, Chadi A.
    Butcher, Brandon D.
    Burns, Trudy L.
    Coryell, William H.
    Schlechte, Janet A.
    Zemel, Babette S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (10) : 2230 - 2237
  • [37] A comparison of total direct medical costs to managed care of escitalopram versus venlafaxine XR treatment in major depressive disorder
    Erder, M. H.
    Wang, C.
    Jonas, J. M.
    VALUE IN HEALTH, 2007, 10 (03) : A77 - A77
  • [38] A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder
    Shelton, Richard C.
    Haman, Kirsten L.
    Rapaport, Mark H.
    Kiev, Ari
    Smith, Ward T.
    Hirschfeld, Robert M. A.
    Lydiard, R. Bruce
    Zajecka, John M.
    Dunner, David L.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (11) : 1674 - 1681
  • [39] Carbamazepine Does Not Alter Biochemical Parameters of Bone Turnover in Healthy Male Adults
    S. Brämswig
    A. Zittermann
    H. K. Berthold
    Calcified Tissue International, 2003, 73 : 356 - 360
  • [40] Carbamazepine does not alter biochemical parameters of bone turnover in healthy male adults
    Brämswig, S
    Zittermann, A
    Berthold, HK
    CALCIFIED TISSUE INTERNATIONAL, 2003, 73 (04) : 356 - 360
12345